Skip to main content
Top
Published in: International Journal of Hematology 1/2008

01-07-2008 | Original Article

Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34+ cells with granulocyte colony-stimulating factor and tumor necrosis factor-α

Authors: Yoshinobu Saito, Yong Mei Guo, Makoto Hirokawa, Kunie Saito, Atsushi Komatsuda, Naoto Takahashi, Masumi Fujishima, Naohito Fujishima, Junsuke Yamashita, Kenichi Sawada

Published in: International Journal of Hematology | Issue 1/2008

Login to get access

Abstract

Tumor necrosis factor-α (TNF-α) has been shown to induce the differentiation of CD34+ cells toward dendritic cells (DCs). We have previously shown that DCs are co-generated from human CD34+ cells during erythroid or megakaryocytic differentiation in the presence of TNF-α, and those DCs are able to stimulate autologous T cell proliferation. The aim of this study was to learn whether the co-stimulation of granulocyte colony-stimulating factor (G-CSF) and TNF-α would generate neutrophil progenitors and DCs together from human CD34+ cells, and if this was the case, to clarify the phenotypic and functional characteristics of these DCs. When highly purified human CD34+ cells were cultured for 7 days with G-CSF alone, the generated cells predominantly expressed a granulocyte marker, CD15, and then differentiated into neutrophils after 14 days of culture. The addition of TNF-α with G-CSF markedly decreased the number of CD15+ cells without affecting the total number of cells during 7 days of culture. Almost one third of the generated cells were positive for CD11c and CD123. Furthermore, CD11c+ cells were found to phagocytose CD15+ cells and were able to induce allogeneic, but not autologous, T cell proliferation in the mixed lymphocyte reaction (MLR). On the other hand, the CD11c+ cells generated by TNF-α and cytokines capable of inducing erythroid differentiation were able to stimulate autologous T cells. There was a difference in the expression of CD80, CD83 and CD86 among CD11c+ cells induced by G-CSF plus TNF-α and those generated by interleukin-3, stem cell factor, and erythropoietin plus TNF-α. These results indicate that the co-stimulation of human CD34+ cells with G-CSF and TNF-α induces the phagocytosis of co-developing neutrophil progenitors by DCs, and the stimulatory effects of these DCs on autologous T cells is different from that of DCs generated from CD34+ cells during erythroid differentiation.
Literature
1.
go back to reference Fukaya H, Xiao W, Inaba K, Suzuki Y, Hirokawa M, Kawabata Y, et al. Co-development of dendritic cells along with erythroid differentiation from human CD34+ cells by tumor necrosis factor-α. Exp Hematol. 2004;32:450–60.CrossRefPubMed Fukaya H, Xiao W, Inaba K, Suzuki Y, Hirokawa M, Kawabata Y, et al. Co-development of dendritic cells along with erythroid differentiation from human CD34+ cells by tumor necrosis factor-α. Exp Hematol. 2004;32:450–60.CrossRefPubMed
2.
go back to reference Saito K, Hirokawa M, Inaba K, Fukaya H, Kawabata Y, Komatsuda A, et al. Phagocytosis of co-developing megakaryocytic progenitors by dendritic cells in culture with thrombopoietin and tumor necrosis factor-α and its possible role in hemophagocytic syndrome. Blood. 2006;107:1366–74.CrossRefPubMed Saito K, Hirokawa M, Inaba K, Fukaya H, Kawabata Y, Komatsuda A, et al. Phagocytosis of co-developing megakaryocytic progenitors by dendritic cells in culture with thrombopoietin and tumor necrosis factor-α and its possible role in hemophagocytic syndrome. Blood. 2006;107:1366–74.CrossRefPubMed
3.
go back to reference Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, et al. Opposite effect of tumor necrosis factor α on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Cancer Res. 1990;50:5065–71.PubMed Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, et al. Opposite effect of tumor necrosis factor α on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Cancer Res. 1990;50:5065–71.PubMed
4.
go back to reference Caux C, Vanbervliet B, Massacrier C, Durand I, Banchereau J. Interleukin-3 cooperates with tumor necrosis factor α for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood. 1996;87:2376–85.PubMed Caux C, Vanbervliet B, Massacrier C, Durand I, Banchereau J. Interleukin-3 cooperates with tumor necrosis factor α for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood. 1996;87:2376–85.PubMed
5.
go back to reference Kawarada Y, Miura N, Sugiyama T. Antibody against single-stranded DNA useful for detecting apoptotic cells recognizes hexadeoxynucleotides with various base sequences. J Biochem. 1998;123:492–8.CrossRefPubMed Kawarada Y, Miura N, Sugiyama T. Antibody against single-stranded DNA useful for detecting apoptotic cells recognizes hexadeoxynucleotides with various base sequences. J Biochem. 1998;123:492–8.CrossRefPubMed
6.
go back to reference Oda A, Sawada K, Druker BJ, Ozaki K, Takano H, Koizumi K, et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Blood. 1998;92:443–51.PubMed Oda A, Sawada K, Druker BJ, Ozaki K, Takano H, Koizumi K, et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Blood. 1998;92:443–51.PubMed
7.
go back to reference Komatsuda A, Wakui H, Imai H, Nakamoto Y, Miura AB, Itoh H, et al. Renal localization of the constitutive 73-kDa heat-shock protein in normal and PAN rats. Kidney Int. 1992;41:1204–12.CrossRefPubMed Komatsuda A, Wakui H, Imai H, Nakamoto Y, Miura AB, Itoh H, et al. Renal localization of the constitutive 73-kDa heat-shock protein in normal and PAN rats. Kidney Int. 1992;41:1204–12.CrossRefPubMed
8.
go back to reference Yamaguchi M, Sawada K, Sato N, Koizumi K, Sekiguchi S, Koike T. A rapid nylon-fiber syringe system to deplete CD14+ cells for positive selection of human blood CD34+ cells. Use of immunomagnetic microspheres. Bone Marrow Transplant. 1997;19:373–9.CrossRefPubMed Yamaguchi M, Sawada K, Sato N, Koizumi K, Sekiguchi S, Koike T. A rapid nylon-fiber syringe system to deplete CD14+ cells for positive selection of human blood CD34+ cells. Use of immunomagnetic microspheres. Bone Marrow Transplant. 1997;19:373–9.CrossRefPubMed
9.
go back to reference Young JW, Szabolcs P, Moore MA. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med. 1995;182:1111–9.CrossRefPubMed Young JW, Szabolcs P, Moore MA. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med. 1995;182:1111–9.CrossRefPubMed
10.
go back to reference Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392:86–9.CrossRefPubMed Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392:86–9.CrossRefPubMed
11.
go back to reference Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, et al. The CD8+ dendritic subset selectively endocytoses dying cells in culture and in vitro. J Exp Med. 2002;195:1289–302.CrossRefPubMedPubMedCentral Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, et al. The CD8+ dendritic subset selectively endocytoses dying cells in culture and in vitro. J Exp Med. 2002;195:1289–302.CrossRefPubMedPubMedCentral
12.
go back to reference Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol. 1998;161:1947–53.PubMed Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol. 1998;161:1947–53.PubMed
13.
go back to reference Fujii S, Fujimoto K, Shimizu K, Ezaki T, Kawano F, Takatsuki K, et al. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lympocytes against leukemic cells in acute myelogenous leukemia patients. Cancer Res. 1999;59:2150–8.PubMed Fujii S, Fujimoto K, Shimizu K, Ezaki T, Kawano F, Takatsuki K, et al. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lympocytes against leukemic cells in acute myelogenous leukemia patients. Cancer Res. 1999;59:2150–8.PubMed
14.
go back to reference Koski GK, Schwartz GN, Weng DE, Gress RE, Engels FH, Tsokos M, et al. Calcium ionophore-treated myeloid cells acquire many dendritic cells characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood. 1999;94:1359–71.PubMed Koski GK, Schwartz GN, Weng DE, Gress RE, Engels FH, Tsokos M, et al. Calcium ionophore-treated myeloid cells acquire many dendritic cells characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood. 1999;94:1359–71.PubMed
15.
go back to reference van Gisbergen KP, Sanchez-Hernandez M, Geijtenbeek TB, van Kooyk Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med. 2005;201:1281–92.CrossRefPubMedPubMedCentral van Gisbergen KP, Sanchez-Hernandez M, Geijtenbeek TB, van Kooyk Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med. 2005;201:1281–92.CrossRefPubMedPubMedCentral
16.
go back to reference Megiovanni AM, Sanchez F, Robledo-Sarmiento M, Morel C, Gluckman JC, Boudaly S. Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes. J Leukoc Biol. 2006;79:977–88.CrossRefPubMed Megiovanni AM, Sanchez F, Robledo-Sarmiento M, Morel C, Gluckman JC, Boudaly S. Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes. J Leukoc Biol. 2006;79:977–88.CrossRefPubMed
17.
go back to reference Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 2001;106:263–6.CrossRefPubMed Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 2001;106:263–6.CrossRefPubMed
18.
19.
go back to reference Pardoll DM. Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol. 2002;2:227–38.CrossRefPubMed Pardoll DM. Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol. 2002;2:227–38.CrossRefPubMed
20.
go back to reference Dilioglou S, Cruse JM, Lewis RE. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Exp Mol Pathol. 2003;75:217–27.CrossRefPubMed Dilioglou S, Cruse JM, Lewis RE. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Exp Mol Pathol. 2003;75:217–27.CrossRefPubMed
21.
go back to reference Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685–711.CrossRefPubMed Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685–711.CrossRefPubMed
22.
go back to reference Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol. 2005;175:1373–81.CrossRefPubMed Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol. 2005;175:1373–81.CrossRefPubMed
23.
go back to reference Baumeister SH, Hölig K, Bornhäuser M, Meurer M, Peter Rieber E, Schäkel K. G-CSF mobilizes slanDC (6-sulfo LacNAc + dendritic cells) with a high proinflammatory capacity. Blood. 2007;110:3078–81.CrossRefPubMed Baumeister SH, Hölig K, Bornhäuser M, Meurer M, Peter Rieber E, Schäkel K. G-CSF mobilizes slanDC (6-sulfo LacNAc + dendritic cells) with a high proinflammatory capacity. Blood. 2007;110:3078–81.CrossRefPubMed
24.
go back to reference Ward KA, Stewart LA, Schwarer AP. CD34+-derived CD11c+++ BDCA-1++ CD123++ DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy. Cytotherapy. 2006;8:130–40.CrossRefPubMed Ward KA, Stewart LA, Schwarer AP. CD34+-derived CD11c+++ BDCA-1++ CD123++ DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy. Cytotherapy. 2006;8:130–40.CrossRefPubMed
Metadata
Title
Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34+ cells with granulocyte colony-stimulating factor and tumor necrosis factor-α
Authors
Yoshinobu Saito
Yong Mei Guo
Makoto Hirokawa
Kunie Saito
Atsushi Komatsuda
Naoto Takahashi
Masumi Fujishima
Naohito Fujishima
Junsuke Yamashita
Kenichi Sawada
Publication date
01-07-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0098-z

Other articles of this Issue 1/2008

International Journal of Hematology 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine